CT影像列线图模型术前预测食管鳞癌新辅助免疫化疗后增大的区域淋巴结转移的价值OA
A CT-based nomogram for preoperative prediction of metastatic enlarged regional lymph nodes after neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma
目的 基于增强CT影像主观特征构建列线图模型,探讨模型对食管鳞癌(ESCC)新辅助免疫化疗(nICT)后增大的区域淋巴结转移风险的预测价值.方法 回顾性纳入3家医疗中心于nICT后接受手术的局部晚期ESCC病人60例,根据nICT治疗后CT影像共评估81枚影像学增大的区域淋巴结(均具有匹配的病理结果).评估淋巴结的长径(LAD)、短径(SAD)及多项影像学主观特征.采用单因素及多因素Logistic回归分析筛选淋巴结转移的独立预测因素,并构建列线图模型.通过受试者操作特征(ROC)曲线及曲线下面积(AUC)评价模型判别能力,采用DeLong检验比较不同模型的预测效能.利用Bootstrap重抽样进行内部验证,通过一致性指数(C指数)、校准曲线和决策曲线分析(DCA)评估模型的区分度、校准度和临床实用性.结果 多因素分析显示,长径变化率(ΔLAD)较小、存在影像学包膜外侵犯(iENE)以及肾形形态的消失是淋巴结转移的独立预测因素.基于上述变量构建的列线图模型表现出良好的预测效能,原始C指数为0.903,经内部验证后为0.893.该模型的AUC达0.903,敏感度90.0%,特异度78.7%,其预测效能显著高于各单一因素的预测效能(均P<0.05).校准曲线显示预测概率与实际观察值一致性良好.决策曲线分析显示,在阈值概率 0.10~0.75 范围内,联合模型获得更高净获益.此外,ΔLAD>27%可作为鉴别反应性增生的有效截断值(敏感度75%,特异度63.9%).结论 基于增强CT影像学特征构建的列线图模型可有效预测nICT后ESCC病人增大区域淋巴结的转移状态,并能够为临床区分新辅助免疫化疗相关的假性进展与真性转移、制定个体化治疗策略提供实用工具.
Objective To develop a nomogram based on subjective features from contrast-enhanced CT and to evaluate its ability to predict the metastatic risk of enlarged regional lymph nodes after neoadjuvant immunochemotherapy(nICT)in patients with esophageal squamous cell carcinoma(ESCC).Methods This retrospective multicenter study enrolled 60 patients with locally advanced ESCC who underwent nICT followed by surgical resection at three medical centers.A total of 81 radiologically enlarged regional lymph nodes identified on post-nICT CT scans with matched pathological results were analyzed.Long-axis diameter(LAD),short-axis diameter(SAD),and multiple radiologic features of lymph nodes were evaluated.Univariate and multivariate logistic regression analyses were performed to identify independent predictors of nodal metastasis and to construct a nomogram.Model performance was assessed using receiver operating characteristic(ROC)curves and the area under the curve(AUC),with DeLong's test used for comparisons.Internal validation was conducted using bootstrap resampling.Model discrimination,calibration,and clinical utility were evaluated using the concordance index(C-index),calibration curves,and decision curve analysis(DCA),respectively.Results Multivariate analysis identified a smaller percentage change in LAD(ΔLAD),the presence of radiologic extranodal extension(iENE),and loss of kidney-shaped morphology as independent predictors of lymph node metastasis.The nomogram demonstrated excellent predictive performance,with a C-index of 0.903 and a bootstrap-corrected C-index of 0.893.The AUC of the nomogram was 0.903,with a sensitivity of 90.0%and specificity of 78.7%,significantly outperforming any single imaging feature alone(all P<0.05).Calibration curves showed good agreement between predicted probabilities and observed outcomes.DCA indicated that the combined model provided a higher net benefit across a wide range of threshold probabilities(0.10-0.75).In addition,a ΔLAD cutoff value greater than 27%effectively differentiated reactive nodal enlargement from metastatic nodes,with a sensitivity of 75.0%and specificity of 63.9%.Conclusion The CT-based nomogram developed in this study enables reliable preoperative prediction of metastatic status in enlarged regional lymph nodes after nICT in ESCC patients.This model may serve as a practical imaging tool to distinguish immune-related pseudoprogression from true nodal metastasis and to facilitate individualized treatment planning.
陈嘉慧;高莹莹;宁梓妤;李欣明;韩路军;谢辰仪;胡艺怀;刘再毅
华南理工大学医学院,广州 510006南方医科大学附属广东省人民医院(广东省医学科学院)广东省医学影像智能分析与应用重点实验室山东中医药大学附属山东省中医院放射科南方医科大学附属广东省人民医院(广东省医学科学院)南方医科大学珠江医院骨科中山大学肿瘤防治中心影像科南方医科大学附属广东省人民医院(广东省医学科学院)
医药卫生
食管癌淋巴结转移新辅助免疫化疗列线图
Esophageal neoplasmsLymphatic metastasisNeoadjuvant immunochemotherapyNomogram
《国际医学放射学杂志》 2026 (1)
13-21,9
国家青年科学基金(82302299,82202840)中国博士后科学基金(2022M720853,2023T160134)
评论